Skip to main content
logo
Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
5.05
-0.15 (-2.88%)
At close: Sep 1, 2026, 4:00 PM EDT
5.07
+0.02 (0.40%)
Pre-market: Sep 2, 2026, 5:56 AM EDT

Unicycive Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.680.95-
Revenue Growth
----29.02%--
Gross Profit
---0.680.95-
Operating Income
-33.13-29.52-32.12-20.77-18.05-8.98
Net Income
-35.22-26.56-37.82-31.41-18.06-10.02
Earnings Per Share
-1.56-1.67-5.65-12.80-11.99-8.58
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
61.4341.2726.149.70.4616.58
Total Debt
0.670.120.680.790.160.31
Net Cash (Debt)
60.7541.1525.468.910.316.27
Net Cash Growth
177.19%61.63%185.82%2869.33%-98.16%-
Net Cash Per Share
2.692.593.803.630.2013.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-27.84-31.32-28.58-18.28-15.65-5.77
Capital Expenditures
-0.01-0.02-0.07-0.01-0-0.03
Free Cash Flow
-27.85-31.34-28.65-18.3-15.65-5.8
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%100.00%-
Operating Margin
----3077.63%-1898.21%-
Pretax Margin
----4525.04%-1898.84%-
Profit Margin
----4653.48%-1898.84%-
FCF Margin
----2710.37%-1645.95%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-1.67----
PS Ratio
---44.688.57-